New system for assessing the prognosis of refractory anemia patients

Leukemia

Volumn 13, Issue 11, 1999, Pages 1727-1734

  Matsuda, A ^a   Jinnai, I ^b   Yagasaki, F ^a   Kusumoto, S ^a   Murohashi, I ^a   Bessho, M ^a   Hirashima, K ^a   Honda, S ^b   Minamihisamatsu, M ^c   Fuchigami, K ^b   Matsuo, T ^b   Kuriyama, K ^b   Tomonaga, M ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

MDS; Micromegakaryocyte; Prognosis; Pseudo Pelger Huet anomalies; RA

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE; AGED; ARTICLE; CANCER SURVIVAL; CELL STRUCTURE; CLINICAL FEATURE; CYTOGENETICS; CYTOPENIA; FEMALE; GENDER; HUMAN; HUMAN CELL; KARYOTYPE; LEUKOCYTE DISORDER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; RISK ASSESSMENT;

EID: 0032717982     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401556     Document Type: Article

References (24)

1. Goasguen JE, Bennett JM. Classification and morphologic features of the myelodysplastic syndromes. Semin Oncol 1992; 19: 4-13.
2. Ganser A, Hoelzer D. Clinical course of myelodysplastic syndromes. Hematol Oncol Clin N Am 1992; 6: 607-617.
3. Koeffler HP. Introduction: myelodysplastic syndromes. Semin Hematol 1996; 33: 87-94.
4. Hofmann WK, Ottmann OG, Ganser A, Hoelzer D. Myelodysplastic syndromes: clinical features. Semin Hematol 1996; 33: 177-185.
5. Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 1985; 59: 425-433.
6. Varela BL, Chuang C, Woll JE, Bennet JM. Modifications in the classification of primary myelodysplastic syndromes: the addition of a scoring system. Haematol Oncol 1985; 3: 55-63.
7. Toyama K, Ohyashiki K, Yoshida Y, Abe T, Asano S, Hirai H, Hirashima K, Hotta T, Kuramoto A, Kuriya S, Miyazaki T, Kakishita E, Mizoguchi H, Okada M, Shirakawa S, Takaku F, Tomonaga M, Uchino H, Yasunaga K, Nomura T. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia 1993; 7: 499-508.
8. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
9. Matsuda A, Jinnai I, Yagasaki F, Kusumoto S, Minamihisamatsu M, Honda S, Murohashi I, Bessho M, Hirashima K. Refractory anemia with severe dysplasia: clinical significance of morphological features in refractory anemia. Leukemia 1998; 12: 482-485.
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnic HR, Sultan C. Proposal for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
11. ISCN (1995). Mitelman F (ed). An International System for Human Cytogenetic Nomenclature. Karger: Basel, 1995.
12. Cunningham I, MacCallum SJ, Nicholls MD, Byth K, Hewson JW, Arnold B, Motum PI, Mulligan SP, Crane GG. The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institution. Br J Haematol 1995; 90: 602-606.
13. Fenaux P, Morel P, Lai JL. Cytogenetics of myelodysplastic syndromes. Semin Hematol 1996; 33: 127-138.
14. Gattermann N, Aul C, Schneider W. Two types of acquired sideroblastic anemia (AISA). Br J Haematol 1990; 74: 45-52.
15. Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome. Leukemia 1996; 10: 20-26.
16. Bain BJ. The bone marrow aspirate of healthy subjects. Br J Haematol 1996; 94: 206-209.
17. Hadnagy C, Laszlo GA. Acquired dyserythropoiesis in liver disease. Br J Haematol 1991; 78: 283.
18. Karcher DS, Frost AR. The bone marrow in human immunodeficiency virus (HIV)-related disease. Morphology and clinical correlation. Am J Clin Pathol 1991; 95: 63-71.
19. Kuriyama K, Tomonaga M, Matsuo T, Ginnai I, Ichimaru M. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome. Br J Haematol 1986; 63: 665-669.
20. Soenen V, Preudhomme C, Roumier C, Daudignon A, Lai JL, Fenaux P. 17p deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ. Blood 1998; 91: 1008-1015.
21. Bouscary D, Preudhomme C, Ribrag V, Melle J, Viguie F, Picard F, Guesnu M, Fenaux P, Gisselbrecht S, Dreyfus F. Prognostic value of c-mpl expression in myelodysplastic syndromes. Leukemia 1995; 9: 783-738.
22. Oguma S, Yoshida Y, Uchino H, Maekawa T, Nomura T, Mizoguchi H, the Refractory Anemia Study Group of the Ministry of Health anf Welfare. Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Leukemia Res 1995; 19: 219-225.
23. Intragumtornchai T, Prayoonwiwat W, Swasdikul D, Suwanwela N, Chaimongkol B, Jootar S, Chansung K, Chancharunee S, Leelasiri A, Yoshida Y. Myelodysplastic syndrome in Thailand: a retrospective pathologic and clinical analysis of 117 cases. Leukemia Res 1997; 21 (Suppl. 1): S5.
24. Mukiibi JM, Paul B. Myelodysplastic syndrome (MDS) in Central Africans. Trop Geogr Med 1994; 46: 17-19.